Company / Revenue per Share
Mirum Pharmaceuticals, Inc. Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$10.78
FY2025
5-year range
$0.00 / $10.78
FY2021-FY2025
Trend
+49.6%
vs FY2024
Sector context
#44 of 154
Health Care
What the data says
At $10.78, Mirum Pharmaceuticals, Inc.'s revenue per share ranks #44 of 154 in the Health Care sector. Revenue per Share has increased for 4 consecutive years, from $0.00 in FY2021 to $10.78 in FY2025.
Based on SEC 10-K filings.
10.78 in FY2025 with a 3-year CAGR of +158.3%.
Improved from $5.04 to $10.78 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +158.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#44 of 154 in Health CareTop 29% of 154This company $10.78 Sector average $10.35
▼
+4.2% above sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 49.6% year-over-year.
- Ranks #44 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.78 | +49.6% |
| FY2024 | $7.21 | +43.0% |
| FY2023 | $5.04 | +705.9% |
| FY2022 | $0.63 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026